Tcrx Therapeutics Co.ltd

This early-stage study tests a new treatment called KXV01 for people with advanced solid tumors, including bone and soft tissue cancers, who have run out of standard options. The main goal is to check safety and find the right dose. About 30 adults aged 18 to 70 will take part.

This early-stage study tests a new drug called KSV01 in 18 adults with diffuse large B-cell lymphoma that has come back or not responded to prior treatment. The main goal is to check safety and find the right dose. Researchers will monitor side effects and look for signs that the…